Gomes JE da C, Santos PFP dos, Alvarenga VM. CARDIOVASCULAR BENEFITS OF CANAGLIFLOZIN USE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: AN INTEGRATIVE REVIEW. REASE. 2025;11(10):5153-5165. doi:10.51891/rease.v11i10.21802